Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

SpeeDx, GSK Sign Test Supply, Development Deal

SpeeDx said it will work with GlaxoSmithKline on tests to support its antibiotic clinical trials, as well as its new product development efforts.

Adial Pharmaceuticals, Eurofins Scientific Partner on CDx for Alcohol Use Disorder Drug

Eurofins Scientific will help Adial validate a companion diagnostic for a drug being developed and identify patients for enrollment into a Phase III trial.

Macrogen, Exosome Plus Ink MOU, Deal for Exosome Isolation Kits

The South Korean companies have also agreed to work together on the development of exosome-based biomedical products including diagnostics and therapeutics.

Danaher Prices $2.76B Offering of Common, Preferred Stock

Danaher is offering 11 million shares of its common stock at $123 per share and 1.5 million shares of its mandatory convertible preferred stock at $1,000 per share.

Menu

Drug Discovery & Development

SpeeDx, GSK Sign Test Supply, Development Deal

Adial Pharmaceuticals, Eurofins Scientific Partner on CDx for Alcohol Use Disorder Drug

Macrogen, Exosome Plus Ink MOU, Deal for Exosome Isolation Kits

Danaher Prices $2.76B Offering of Common, Preferred Stock

Breaking News

Bio-Techne, Uman Diagnostics Ink License, Supply Agreement for Neurofilament Light Assay

Ortho Clinical Diagnostics Receives CE Mark for Enhanced Cardiac Assay

Quest Diagnostics Q2 Revenues Grow 2 Percent

China's NMPA Extends Approval for Roche Cobas EGFR Mutation Test v2 to Plasma Samples

Curetis Submits Lower Respiratory Tract Infection Test for FDA Clearance

Roche Expands Global Access Program to Include Tuberculosis, Hepatitis, HPV Tests

Sponsorships